The Relationship between Atopic Dermatitis and Food Allergy

Noura Elgharably and Mohammed Al Abadie
Additional contact information
Noura Elgharably: Hereford County Hospital, United Kingdom
Mohammed Al Abadie: UCLAN Medical School, United Kingdom

European Journal of Pharmaceutical Research, 2024, vol. 4, issue 1, 1-4

Abstract: Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterised by an inadequate skin barrier. This can be caused by a variety of reasons such as hereditary predisposition and immunological dysregulation. AD affects 20% of infants, it is the most common chronic inflammatory skin disease in this group, and 3% of adults. It typically manifests as moderate disease, with two-thirds of people with AD unlikely to develop sensitivity to environmental allergens; nonetheless, there have frequently been connections with atopic diseases, particularly IgE-mediated food allergy (FA). Allergy is confirmed with a food challenge test before restricting this in the diet. Up to one-third of children with early-onset AD experience an atopic march, which is characterised by the later development of atopic disorders including asthma, allergic rhinitis and/or rhinoconjunctivitis, food allergies, and hay fever. As a result, AD and food allergy are linked, and recent research shows that AD develops before food sensitisation, and food allergy relates to atopic dermatitis of varied severity.

Keywords: Allergy; Atopic Dermatitis; Radioallergosorbent (RAST test) (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/pharma/article/view/775 Abstract page (text/html)
https://eu-opensci.org/index.php/pharma/article/download/775/321 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:pharma:v:4:y:2024:i:1:id:775

DOI: 10.24018/ejpharma.2024.4.1.75

Access Statistics for this article

More articles in European Journal of Pharmaceutical Research from European Open Science Publishing
Bibliographic data for series maintained by Support Team ().